ChemInform Abstract: Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as New Promising Drugs for...

1
2002 biochemistry, review biochemistry, review Z 0250 37 - 283 Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as New Promising Drugs for Diabetes, Neurodegeneration, Cancer, and Inflammation [81 refs.]. — (MARTINEZ, ANA; CASTRO, ANA; DORRONSORO, ISABEL; ALONSO, MERCEDES; Med. Res. Rev. 22 (2002) 4, 373-384; Inst. Quim. Med., CSIC, E-28006 Madrid, Spain; EN) 1

Transcript of ChemInform Abstract: Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as New Promising Drugs for...

Page 1: ChemInform Abstract: Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as New Promising Drugs for Diabetes, Neurodegeneration, Cancer, and Inflammation

2002 biochemistry, review

biochemistry, reviewZ 0250

37 - 283Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as New PromisingDrugs for Diabetes, Neurodegeneration, Cancer, and Inflammation— [81 refs.]. — (MARTINEZ, ANA; CASTRO, ANA; DORRONSORO,ISABEL; ALONSO, MERCEDES; Med. Res. Rev. 22 (2002) 4, 373-384; Inst.Quim. Med., CSIC, E-28006 Madrid, Spain; EN)

1